MEDICOX Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was KRW 7,635.73 million compared to KRW 5,553.56 million a year ago. Net loss was KRW 9,531 million compared to KRW 5,792.25 million a year ago. Basic loss per share from continuing operations was KRW 340 compared to KRW 304 a year ago. Diluted loss per share from continuing operations was KRW 340. Basic loss per share was KRW 340 compared to KRW 304 a year ago.
For the six months, sales was KRW 243.18 million compared to KRW 0.00013 million a year ago. Net loss was KRW 13,068.38 million compared to KRW 7,434.77 million a year ago. Basic loss per share from continuing operations was KRW 485 compared to KRW 388 a year ago. Diluted loss per share from continuing operations was KRW 485 compared to KRW 388 a year ago. Basic loss per share was KRW 485 compared to KRW 388 a year ago.